TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

Drugmakers Plan Fresh Price Hikes On 350 Medicines In 2026

Benzinga Logo Benzinga By Vandana Singh
Drugmakers Plan Fresh Price Hikes On 350 Medicines In 2026

Major pharmaceutical companies are planning price increases on at least 350 branded medicines in 2026, with a median increase of about 4%. This includes vaccines and cancer therapies, despite pressure from the Trump administration to control drug costs. Only nine drugs will see price cuts, including Jardiance which faces a 40%+ reduction following government negotiations.

Insights
GSK   negative

Planning price increases on multiple medicines in 2026 despite regulatory pressure, which may face public and political backlash